期刊文献+

顺尔宁治疗成人哮喘的有效性及安全性临床观察 被引量:4

下载PDF
导出
出处 《临床肺科杂志》 2004年第4期426-427,共2页 Journal of Clinical Pulmonary Medicine
  • 相关文献

参考文献7

  • 1徐青,邓伟吾.白三烯受体拮抗剂及合成抑制剂与哮喘[J].中国新药与临床杂志,2000,19(3):216-219. 被引量:49
  • 2支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2007
  • 3Barnes NC,Piper PJ,Costello JF.Comparative effects of inhaled leukotriene C4|leudotriene D4 and histamine in normal human subjects.Thorax 1984,39: 500- 504.
  • 4Davidson AB,Lee TH,Scanion PD,et al.Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects.Am Rev Respir Dis 1987,135: 500~ 504.
  • 5孟鲁司特临床试验协作组.白三烯受体拮抗剂孟鲁司特治疗轻中度哮喘疗效和安全性评价[J].中华结核和呼吸杂志,2002,25(3):180-181. 被引量:70
  • 6Reiss TF,Chervinsky P,Edwards T,et al.Montelukast (MK0476 ).a CysLT1 receptor antagonist,improves the sigs and symptoms of asthma over a 3 month treatment period [abstract].Eur Respir J 1996 Sep;9 Suppl.23:273.
  • 7Schoor DF,De Smet M,Reiss T,et al.Single dose pharmacokinetics,safety and tolerability of MK- 0476,a new leukotriene D4- receptor antagonist,in healthy volunteers.Br Clin Pharmacol 1995 Sep;40:277~280

二级参考文献5

  • 1Wang C G,Am Rev Respir Dis,1993年,148卷,413页
  • 2Hui K P,Lancet,1991年,337卷,1062页
  • 3Edelman JM,Turpin JA,Bronsky EA.Oral montelukast Compared with inhaled salmeterol to prevent exercise-induced bronchoconstrictrion[].Annals of Internal Medicine.2000
  • 4O′Byrne PM.Leukotriene Bronchoconstriction induced by allergen and exercise[].American Journal of Respiratory and Critical Care Medicine.2000
  • 5Taylor IK,Willings R,Toylor GW,et al.Urinary leukotriene E4 excretion in exercise induced asthma[].Journal of Applied Physiology.1992

共引文献2118

同被引文献29

  • 1曹玲,陈育智.孟鲁司特治疗儿童哮喘的有效性及安全性观察[J].中华微生物学和免疫学杂志,2001,21(S2):65-67. 被引量:22
  • 2夏雯,葛传生,潘晓勤,韩青.卡介菌多糖核酸对变应性哮喘患儿T辅助细胞亚群平衡的影响[J].江苏医药,2004,30(9):684-686. 被引量:1
  • 3倪树芳,郭玉兰,陶虹.顺尔宁联合盐酸班布特罗口服液治疗咳嗽变异性哮喘疗效观察[J].中原医刊,2004,31(22):6-7. 被引量:4
  • 4刘光耀,李涛,杨晓.孟鲁司特的不良反应与安全应用[J].药物不良反应杂志,2005,7(2):116-117. 被引量:13
  • 5Garcia ML,Wahn U,Gills L,et al.Montelukast,compared with fluticasone,for control of asthma among 6 to 14 year-old patients with mild asthma:the MOSAIC study[J].Padiatrics,2005,116(2):360-369.
  • 6Jenkins CR,Thien FC,Wheatley JR,et al.Traditional and patient centred outcomes with three classes of asthma medication[J].Eur Respir J,2005,26(1):36-44.
  • 7Ostrom NK,Decotis BA,Lincourt WR,et al.Comparative efficacy and of low-dose fluticsasone propionate and montelukast in children with pereietent asthma[J].J Peadiatr,2005,147(2):213-220.
  • 8Garcia ML,Wahn U,Gills L,et al.Montelukast,compared with fluticasone,for control of asthma among 6 to 14 year-old patients with mild asthma:the MOSAIC study[J].Padiatrics,2005,116(2):360-9
  • 9Zeiger RS,Bird SR,Kaplan MS,et al.Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone:a randomized controlled trial[J].Am J Med,2005,118(6):649-657
  • 10Brozmanova M,Plevkova J,Bartos V,et al.Antieukotriene treatmrnt and allergic rhinitis-related cough in guinea pigs[J].J Physio Pharmaco,2005,56(supp 4):21-30

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部